BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1231 related articles for article (PubMed ID: 8714789)

  • 1. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE; Ashton T
    N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Self dialysis: a new method of treatment for end-stage renal disease].
    Fournier G; Gaillard JL; Matha N; Man NK
    Nephrologie; 1984; 5(3):115-8. PubMed ID: 6493429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.
    Rodríguez-Carmona A; Perez Fontán M; Bouza P; García Falcón T; Valdés F
    Adv Perit Dial; 1996; 12():93-6. PubMed ID: 8865880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada.
    McFarlane PA
    Semin Dial; 2004; 17(2):118-24. PubMed ID: 15043613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
    Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
    Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
    Lee H; Manns B; Taub K; Ghali WA; Dean S; Johnson D; Donaldson C
    Am J Kidney Dis; 2002 Sep; 40(3):611-22. PubMed ID: 12200814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I
    Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
    [No Abstract]   [Full Text] [Related]  

  • 11. [Renal function substitutes. Technical and logistic orientation of the treatment].
    Legrain M; Rottembourg J
    Ann Med Interne (Paris); 1982; 133(8):611-24. PubMed ID: 6763488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-care dialysis fits in with new economic challenges for providers.
    Usewicz MC
    Nephrol News Issues; 2011 Aug; 25(9):34-5. PubMed ID: 21905529
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of end-stage renal disease in Alabama.
    Melnick S
    Ala J Med Sci; 1983 Oct; 20(4):456-9. PubMed ID: 6359945
    [No Abstract]   [Full Text] [Related]  

  • 14. Health economic evaluations: the special case of end-stage renal disease treatment.
    Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
    Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patients.
    Coyte PC; Young LG; Tipper BL; Mitchell VM; Stoffman PR; Willumsen J; Geary DF
    Am J Kidney Dis; 1996 Apr; 27(4):557-65. PubMed ID: 8678067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost of dialysis in France].
    Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
    Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].
    Canaud B; Mion C
    Nephrologie; 1995; 16(1):129-35. PubMed ID: 7700413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of end-stage chronic renal failure in Switzerland].
    Spertini F; Wauters JP
    Schweiz Med Wochenschr; 1985 May; 115(21):722-7. PubMed ID: 3892661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Medicare cost of renal dialysis. Evidence from a statistical cost function.
    Dor A; Held PJ; Pauly MV
    Med Care; 1992 Oct; 30(10):879-91. PubMed ID: 1405794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dialysis facility of the future: the financial and social environment.
    Steinman TI
    Semin Nephrol; 1997 Jul; 17(4):298-305. PubMed ID: 9241715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.